| Literature DB >> 29295606 |
Sadanori Akita1,2, Kenji Hayashida3,4, Hiroshi Yoshimoto5, Masaki Fujioka6, Chikako Senju7,8, Shin Morooka9, Gozo Nishimura10, Nobuhiko Mukae11, Kazuo Kobayashi12, Kuniaki Anraku13, Ryuichi Murakami14, Akiyoshi Hirano15, Masao Oishi16, Shintaro Ikenoya17, Nobuyuki Amano18, Hiroshi Nakagawa19.
Abstract
Cultured epithelial autografts (CEA) with highly expanded mesh skin grafts were used for extensive adult burns covering more than 30% of the total body surface area. A prospective study on eight patients assessed subjective and objective findings up to a 12-month follow-up. The results of wound healing for over 1:6 mesh plus CEA, gap 1:6 mesh plus CEA, and 1:3 mesh were compared at 3, 6, and 12 months using extensibility, viscoelasticity, color, and transepidermal water loss by a generalized estimating equation (GEE) or generalized linear mixed model (GLMM). No significant differences were observed among the paired treatments at any time point. At 6 and 12 months, over 1:6 mesh plus CEA achieved significantly better expert evaluation scores by the Vancouver and Manchester Scar Scales (p < 0.01). Extended skin grafting plus CEA minimizes donor resources and the quality of scars is equal or similar to that with conventional low extended mesh slit-thickness skin grafting such as 1:3 mesh. A longitudinal analysis of scars may further clarify the molecular changes of scar formation and pathogenesis.Entities:
Keywords: assessment of scar quality; cultured epithelial autografts (CEA); generalized estimating equation (GEE); generalized linear mixed model (GLMM); split-thickness skin grafting
Mesh:
Year: 2017 PMID: 29295606 PMCID: PMC5796007 DOI: 10.3390/ijms19010057
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
The Vancouver Scar Scale (VSS) and the Manchester Scar Scale (MSS), at 6 and 12 months among gap 1:6 mesh plus CEA, over 1:6 mesh plus cultured epithelial autografts (CEA), and 1:3 mesh.
| Graft Type | 6 Months | 12 Months | ||
|---|---|---|---|---|
| VSS (Mean ± SE) | MSS (Mean ± SE) | VSS (Mean ± SE) | MSS (Mean ± SE) | |
| 1:6 gap + CEA | 6.6 (0.60) | 12.7 (0.81) | 5.6 (041) | 10.7 (0.70) |
| 1:6 over + CEA | 4.1 (0.50) ** | 8.7 (0.40) ** | 2.6 (0.40) ** | 7.3 (0.41) ** |
| 1:3 skin grafting | 5.8 (0.50) | 10.9 (0.61) | 5.1 (0.20) | 10.2 (0.40) |
** p < 0.01.
Criteria for patients to participate in the present study. TBSA: total body surface area.
| Inclusion Criteria |
|---|
| 20 years of age or older |
| Acute full-thickness burn wounds that require widely meshed skin grafting |
| Minimal TBSA of 30% with full thickness wounds |
| Minimal study wound area of 100 cm2 |
| Maximal study wound area of 300 cm2 |
| Informed consent |
| Exclusion criteria |
| Immunocompromised patients or immunosuppressed physical conditions |
| Non-compliance by the patient, judged by medical experts |
| Active infected wounds |
| Known drug allergy |
Patient demographics. PBI: prognostic burn index. wks: weeks.
| Case | Age | Sex | Burn Depth and Percent | TBSA | PBI | How to Reconstruct “Dermis“ | Body Surface Area (m2) | Frequency of Grafts | Number of Sheets | Total CEA Covered BSA (%) | Percent Epithelialization at Four Weeks (%) | Prognosis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 56 | M | DDB 5% | 45 | 98 | Terudermis | 1.441 | 2 | 20 + 20 | 22.2 | 100 | survive |
| 2 | 59 | M | DDB 30% | 40 | 84 | none | 1.6705 | 1 | 7 | 3.4 | 100 | survive |
| 3 | 31 | M | DDB 30% | 40 | 56 | none | 1.8623 | 1 | 20 | 8.6 | 100 | survive |
| 4 | 41 | M | DDB 10% | 50 | 86 | Integra® | 1.9984 | 1 | 32 + 12 | 17.1 | 50 | survive |
| 5 | 63 | M | DDB 20% | 45 | 98 | Integra® | 1.5958 | 2 | 20 + 20 | 20.1 | 100 | survive |
| 6 | 53 | F | DDB 35% | 40 | 78 | Integra® | 1.42 | 1 | 22 | 12.4 | 95 | survive |
| 7 | 70 | M | DDB 10% | 49 | 114 | Integra® | 1.7985 | 2 | 24 + 11 | 15.6 | 50 | deseased at 8 months |
| 8 | 46 | M | DDB 5% | 50 | 91 | Integra® | 1.98 | 2 | 30 + 30 | 24.2 | 95 | survive |
Figure 1Schematic cross-section of 1:3 mesh without CEA (JACE®), (A) and 1:6 mesh plus CEA (JACE®) coverage, (B).
Figure 2Measurement points of the gap 1:6 gap mesh plus CEA or over 1:6 mesh plus CEA (A) and 1:3 mesh (B).
Models for generalized estimating equation (GEE) and generalized linear mixed model (GLMM) analyses.
| Linearity | Intercept | Slope | Selected Statistics | |
|---|---|---|---|---|
| Model 1 | non-linear | fixed | fixed | GEE |
| Model 2 | linear | fixed | fixed | GEE |
| Model 3 | linear | random | random | GLMM |
| Model 4 | linear | random | fixed | GLMM |
Value of each parameter (3, 6 and 12 months).
| Parameter | Over 1:6 Mesh Plus CEA (Mean ± SE) | Gap 1:6 Mesh Plus CEA (Mean ± SE) | 1:3 Mesh (Mean ± SE) |
|---|---|---|---|
|
| |||
| Maximal extensibility (R0) | 67.0 (±13.52) | 62.6 (±8.48) | 69.7 (±5.58) |
| Viscoelasticity (R7) | 126.6 (±18.67) | 93.7 (±13.06) | 108.2 (±14.87) |
| Melanin Index | 97.9 (±12.24) | 118.1 (±15.80) | 123.4 (±35.54) |
| Hemoglobin Index | 133.2 (±11.89) | 155.2 (±13.68) | 144.7 (±14.16) |
| Transepidermal Water Loss (TEWL) | 177.7 (±49.34) | 160.3 (±32.44) | 191.9 (±50.31) |
| Clarity | 84.9 (±4.01) | 79.9 (±3.21) | 85.9 (±3.23) |
| Red | 172.2 (±21.65) | 181.7 (±19.87) | 179.7 (±25.21) |
| Yellow | 72.7 (±4.30) | 66.9 (±3.99) | 75.9 (±5.60) |
|
| |||
| Maximal extensibility (R0) | 70.1 (±11.06) | 67.5 (±9.48) | 75.3 (±6.00) |
| Viscoelasticity (R7) | 118.0 (±16.20) | 87.3 (±11.23) | 95.1 (±12.53) |
| Melanin Index | 107.1 (±16.25) | 121.2 (±17.18) | 124.8 (±30.55) |
| Hemoglobin Index | 135.2 (±12.38) | 150.2 (±13.73) | 141.0 (±13.83) |
| Transepidermal Water Loss (TEWL) | 158.4 (±37.52) | 155.1 (±20.30) | 170.5 (±40.77) |
| Clarity | 86.8 (±3.74) | 82.7 (±3.15) | 87.8 (±2.82) |
| Red | 161.6 (±20.63) | 182.8 (±17.61) | 166.6 (±24.01) |
| Yellow | 77.2 (±4.98) | 70.6 (±3.73) | 80.4 (±5.22) |
|
| |||
| Maximal extensibility (R0) | 76.2 (±10.66) | 77.5 (±15.15) | 86.4 (±8.11) |
| Viscoelasticity (R7) | 100.7 (±15.78) | 74.4 (±9.54) | 68.7 (±9.08) |
| Melanin Index | 125.6 (±26.41) | 127.4 (±21.68) | 127.7 (±24.02) |
| Hemoglobin Index | 139.1 (±15.74) | 140.1 (±20.33) | 133.6 (±15.99) |
| Transepidermal Water Loss (TEWL) | 120.0 (±18.52) | 144.7 (±33.15) | 127.7 (±25.01) |
| Clarity | 90.6 (±3.58) | 88.2 (±3.35) | 91.8 (±2.38) |
| Red | 140.3 (±20.85) | 185.1 (±22.83) | 140.3 (±23.32) |
| Yellow | 86.3 (±6.61) | 77.9 (±4.16) | 89.2 (±5.90) |
Model selection and statistical analysis.
| Selected Model | Comparision | Statistics among Groups | |
|---|---|---|---|
| Maximal extensibility (R0) by a cutometer | Model 4 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Viscoelasticity (R7) by a cutometer | Model 2 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Melanin index by a mexameter | Model 4 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Hemoglobin index by a mexameter | Model 2 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Transepidermal Water Loss (TEWL) by a moisture meter | Model 2 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Clarity by a color meter | Model 4 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Red by a color meter | Model 2 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. | ||
| Yellow by color meter | Model 2 | Over 1:6 vs. Gap 1:6 | n.s. |
| Over 1:6 vs. 1:3 | n.s. | ||
| Gap 1:6 vs. 1:3 | n.s. |
Over 1:6, over 1:6 mesh plus CEA; gap 1:6, gap 1:6 mesh plus CEA, 1:3, 1:3 mesh; n.s.: not significant.